Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
- PMID: 27748052
- PMCID: PMC5119966
- DOI: 10.1002/cam4.932
Irregular vascular pattern by contrast-enhanced ultrasonography and high serum Lens culinaris agglutinin-reactive fraction of alpha-fetoprotein level predict poor outcome after successful radiofrequency ablation in patients with early-stage hepatocellular carcinoma
Abstract
Radiofrequency ablation (RFA) is considered the most effective treatment for early-stage hepatocellular carcinoma (HCC) patients unsuitable for resection. However, poor outcome after RFA has occasionally been reported worldwide. To predict such an outcome, we investigated imaging findings using contrast-enhanced ultrasonography (CEUS) with Sonazoid and serum tumor markers before RFA. This study included 176 early-stage HCC patients who had initially achieved successful RFA. Patients were examined using CEUS; their levels of alpha-fetoprotein (AFP), Lens culinaris agglutinin-reactive fraction of AFP (AFP-L3), and des-gamma-carboxy prothrombin before RFA were measured. Sonazoid provided parenchyma-specific contrast imaging and facilitated tumor vascular architecture imaging through maximum intensity projection (MIP). Kaplan-Meier analysis examined cumulative rates of local tumor progression, intrasubsegmental recurrence, and survival; factors associated with these were determined with Cox proportional hazards analysis. Local tumor progression (n = 15), intrasubsegmental recurrence (n = 46), and death (n = 18) were observed. Irregular pattern in MIP classification and serum AFP-L3 level (>10%) before RFA were identified as independent risk factors for local tumor progression and intrasubsegmental recurrence. These two factors were independently associated with poor survival after RFA (irregular pattern in MIP: hazard ratio, (HR) = 8.26; 95% confidence interval, (CI) = 2.24-30.3; P = 0.002 and AFP-L3 > 10%: HR = 2.94; 95% CI = 1.09-7.94; P = 0.033). Irregular MIP pattern by CEUS and high level of serum AFP-L3 were independent risk factors for poor outcome after successful RFA. The Patients with these findings should be considered as special high-risk group in early-stage HCC.
Keywords: Alpha-fetoprotein; contrast-enhanced ultrasonography; hepatocellular carcinoma; intrasubsegmental recurrence; poor survival; radiofrequency ablation.
© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Figures



Similar articles
-
Clinical Significance of Preoperative Hepatocellular Carcinoma With High Lens culinaris Agglutinin-reactive Fraction of Alpha-Fetoprotein, But Low Alpha-Fetoprotein.Anticancer Res. 2019 Feb;39(2):883-889. doi: 10.21873/anticanres.13189. Anticancer Res. 2019. PMID: 30711971
-
Prognostic value of serum AFP, AFP-L3, and GP73 in monitoring short-term treatment response and recurrence of hepatocellular carcinoma after radiofrequency ablation.Asian Pac J Cancer Prev. 2014;15(4):1539-44. doi: 10.7314/apjcp.2014.15.4.1539. Asian Pac J Cancer Prev. 2014. PMID: 24641364
-
Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.Liver Int. 2016 Apr;36(4):580-7. doi: 10.1111/liv.12991. Epub 2015 Nov 18. Liver Int. 2016. PMID: 26503910
-
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.Clin Liver Dis. 2015 May;19(2):309-23. doi: 10.1016/j.cld.2015.01.005. Epub 2015 Feb 27. Clin Liver Dis. 2015. PMID: 25921665 Review.
-
Hepatocellualar carcinoma serum markers.Semin Oncol. 2012 Aug;39(4):410-33. doi: 10.1053/j.seminoncol.2012.05.001. Semin Oncol. 2012. PMID: 22846859 Review.
Cited by
-
Contrast-Enhanced Ultrasound Parameters and D-Dimer: New Prognostic Parameters for Diffuse Large B-Cell Lymphoma.Cancer Manag Res. 2022 Aug 26;14:2535-2544. doi: 10.2147/CMAR.S326173. eCollection 2022. Cancer Manag Res. 2022. PMID: 36051181 Free PMC article.
-
Current role of ultrasound in the diagnosis of hepatocellular carcinoma.J Med Ultrason (2001). 2020 Apr;47(2):239-255. doi: 10.1007/s10396-020-01012-y. Epub 2020 Mar 13. J Med Ultrason (2001). 2020. PMID: 32170489 Free PMC article. Review.
-
Combining serum biomarkers and MRI radiomics to predict treatment outcome after thermal ablation in hepatocellular carcinoma.Am J Transl Res. 2025 Mar 15;17(3):2031-2043. doi: 10.62347/TFRF1430. eCollection 2025. Am J Transl Res. 2025. PMID: 40226017 Free PMC article.
-
Usefulness of Body Position Change during Local Ablation Therapies for the High-Risk Location Hepatocellular Carcinoma.Cancers (Basel). 2024 Mar 3;16(5):1036. doi: 10.3390/cancers16051036. Cancers (Basel). 2024. PMID: 38473393 Free PMC article.
-
Association between quantitative parameters of CEUS and Sall4/Wnt/β-catenin signaling in patients with hepatocellular carcinoma.Cancer Manag Res. 2019 Apr 17;11:3339-3347. doi: 10.2147/CMAR.S199968. eCollection 2019. Cancer Manag Res. 2019. PMID: 31114369 Free PMC article.
References
-
- Torre, L. A. , Bray F., Siegel R. L., Ferlay J., Lortet‐Tieulent J., and Jemal A.. 2012. Global cancer statistics. CA Cancer J. Clin. 2015. 65:87–108. - PubMed
-
- Tateishi, R. , Shiina S., Teratani T., Obi S., Sato S., Koike Y., et al. 2005. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases. Cancer 103:1201–1209. - PubMed
-
- Lee, D. H. , Lee J. M., Lee J. Y., Kim S. H., Yoon J. H., Kim Y. J., et al. 2014. Radiofrequency ablation of hepatocellular carcinoma as first‐line treatment: long‐term results and prognostic factors in 162 patients with cirrhosis. Radiology 270:900–909. - PubMed
-
- Shin, S. , Lee J. M., Kim K. W., Joo I., Han J. K., B. I. Choi , et al. 2014. Postablation assessment using follow‐up registration of CT images before and after radiofrequency ablation (RFA): prospective evaluation of midterm therapeutic results of RFA for hepatocellular carcinoma. AJR Am. J. Roentgenol. 203:70–77. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical